Adherex Technologies, Inc.
Adherex posts net loss of $0.08 per share
Published in Healthcare Finance, Tax and Law Weekly, June 14th, 2006
The net loss for the 3-month period ended March 31, 2006 was $3.5 million, or $0.08 loss per share, compared to a net loss of $3.1 million, or $0.09 loss per share, for the 3-month period ended March 31, 2005. Operating expenses totaled $3.9 million, an increase of 13% over the same period last year.
These operating expenses primarily reflect increased research and development expenditures related to our expanding clinical trial program for ADH-1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AFP Imaging Corp.
AFP Imaging reports 15% increase in sales - ALS Association
Group joins funding partnership for new hunt for amyotrophic lateral sclerosis genes - Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals added to NASDAQ Biotech Index - Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals reports 7% decrease in sales - Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics added to NASDAQ Biotech Index - Advanced Cell Technology, Inc.
Advanced Cell Technology signs cross license of key intellectual property with Kirin - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
